Nonetheless, data from mouse models have indicated that activation of the MBL branch of the lectin pathway can exacerbate atherothrombotic diseases and that pharmacological MBL inhibition is protective against stroke (47), thrombosis (48), and myocardial infarction (49). This evidence concerns the gene MBL2 and Stroke.